Analytical and clinical performance of thyroglobulin autoantibody assays in thyroid cancer follow-up

作者：Katrangi Waddah; Grebe Stephan K G; Algeciras Schimnich Alicia

来源：Clinical Chemistry and Laboratory Medicine, 2017, 55(12): 1987-1994.

DOI：10.1515/cclm-2017-0034

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background:</jats:title><jats:p>While thyroglobulin autoantibodies (TgAb) can result in false low serum thyroglobulin (Tg) immunoassay (IA) measurements, they might also be indicators of disease persistence/recurrence. Hence, accurate TgAb measurement, in addition to Tg quantification, is crucial for thyroid cancer monitoring. We compared the analytical and clinical performance of four commonly used TgAb IAs.</jats:p></jats:sec><jats:sec><jats:title>Methods:</jats:title><jats:p>We measured Tg by mass spectrometry (Tg-MS) and by four pairs of Tg and TgAb IAs (Beckman, Roche, Siemens, Thermo) in 576 samples. Limit of quantitation (LOQ) and manufacturers’ upper reference interval cut-off (URI) were used for comparisons. Clinical performance was assessed by receiving operator characteristics (ROC) curve analysis.</jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p>Quantitative and qualitative agreement between TgAb-IAs was moderate with R</jats:p></jats:sec><jats:sec><jats:title>Conclusions:</jats:title><jats:p>TgAb-IAs show significant qualitative and quantitative differences. For 2 of the 4 TgAb-IAs, using the LOQ improves the detection of interfering TgAbs. All assays showed suboptimal clinical performance when used as surrogate markers of disease, with modest improvements when Tg and TgAb were combined.</jats:p></jats:sec>

• 出版日期2017-12